Susquehanna Fundamental Investments’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Susquehanna Fundamental Investments's BIIB Position: Q1 2022 in Review
Susquehanna Fundamental Investments opened a new position in Biogen (BIIB) in Q1 2022: 48,876 shares worth $10.3M. The stake represents 0.2% of the portfolio and ranks #127 among its holdings. This is a return to the name: Susquehanna Fundamental Investments previously reported a position in BIIB as recently as Q3 2021.
Susquehanna Fundamental Investments first reported a position in BIIB in Q3 2021 and has held it in 2 quarters since. 953 funds tracked by Wall St. Rank hold BIIB as of Q1 2022.
- Susquehanna Fundamental Investments held 48,876 shares of Biogen worth $10.3M as of Q1 2022.
- Biogen was a new Susquehanna Fundamental Investments position in Q1 2022.
- Biogen made up 0.2% of Susquehanna Fundamental Investments's portfolio in Q1 2022, its #127 holding.
- Susquehanna Fundamental Investments first reported a position in Biogen in Q3 2021 and has held it in 2 quarters since.
- 953 funds tracked by Wall St. Rank held Biogen as of Q1 2022.
Based on Susquehanna Fundamental Investments's 13F filing for Q1 2022, filed 16 May 2022.